Report Detail
Global Immunotherapeutic Drugs Market Size, Status and Forecast 2019-2025
- RnM3701519 |
- 27 August, 2019 |
- Global |
- 96 Pages |
- QYResearch |
- Pharma & Healthcare
Immunotherapy is a cancer treatment that enhances the body's natural defenses against cancer-fighting tissues.In this treatment, substances made in the body or laboratory are used to improve or restore immune system function.The drugs used in this treatment are called immunotherapeutics.Immunotherapy drugs are designed to warn the immune system about mutated cells, so it can easily find and destroy them.
In 2018, the global Immunotherapeutic Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Immunotherapeutic Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Immunotherapeutic Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Roche
Merck
Novartis
Johnson & Johnson
GlaxoSmithKline
AbbVie
ELI Lilly
Amgen
AstraZeneca
Bristol-Mysers Squibb
Market segment by Type, the product can be split into
Monoclonal Antibody
Vaccines
Checkpoint Inhibitor
Interferon
Market segment by Application, split into
Hospitals
Clinics
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Immunotherapeutic Drugs status, future forecast, growth opportunity, key market and key players.
To present the Immunotherapeutic Drugs development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Immunotherapeutic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Immunotherapeutic Drugs Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Monoclonal Antibody
- 1.4.3 Vaccines
- 1.4.4 Checkpoint Inhibitor
- 1.4.5 Interferon
- 1.5 Market by Application
- 1.5.1 Global Immunotherapeutic Drugs Market Share by Application (2019-2025)
- 1.5.2 Hospitals
- 1.5.3 Clinics
- 1.5.4 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Immunotherapeutic Drugs Market Size
- 2.2 Immunotherapeutic Drugs Growth Trends by Regions
- 2.2.1 Immunotherapeutic Drugs Market Size by Regions (2019-2025)
- 2.2.2 Immunotherapeutic Drugs Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Immunotherapeutic Drugs Market Size by by Players
- 3.1.1 Global Immunotherapeutic Drugs Revenue by by Players (2014-2019)
- 3.1.2 Global Immunotherapeutic Drugs Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Immunotherapeutic Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Immunotherapeutic Drugs Key Players Head office and Area Served
- 3.3 Key Players Immunotherapeutic Drugs Product/Solution/Service
- 3.4 Date of Enter into Immunotherapeutic Drugs Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Immunotherapeutic Drugs Market Size by Type (2014-2019)
- 4.2 Global Immunotherapeutic Drugs Market Size by Application (2014-2019)
5 North America
- 5.1 North America Immunotherapeutic Drugs Market Size (2014-2019)
- 5.2 Immunotherapeutic Drugs Key Players in North America
- 5.3 North America Immunotherapeutic Drugs Market Size by Type
- 5.4 North America Immunotherapeutic Drugs Market Size by Application
6 Europe
- 6.1 Europe Immunotherapeutic Drugs Market Size (2014-2019)
- 6.2 Immunotherapeutic Drugs Key Players in Europe
- 6.3 Europe Immunotherapeutic Drugs Market Size by Type
- 6.4 Europe Immunotherapeutic Drugs Market Size by Application
7 China
- 7.1 China Immunotherapeutic Drugs Market Size (2014-2019)
- 7.2 Immunotherapeutic Drugs Key Players in China
- 7.3 China Immunotherapeutic Drugs Market Size by Type
- 7.4 China Immunotherapeutic Drugs Market Size by Application
8 Japan
- 8.1 Japan Immunotherapeutic Drugs Market Size (2014-2019)
- 8.2 Immunotherapeutic Drugs Key Players in Japan
- 8.3 Japan Immunotherapeutic Drugs Market Size by Type
- 8.4 Japan Immunotherapeutic Drugs Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Immunotherapeutic Drugs Market Size (2014-2019)
- 9.2 Immunotherapeutic Drugs Key Players in Southeast Asia
- 9.3 Southeast Asia Immunotherapeutic Drugs Market Size by Type
- 9.4 Southeast Asia Immunotherapeutic Drugs Market Size by Application
10 India
- 10.1 India Immunotherapeutic Drugs Market Size (2014-2019)
- 10.2 Immunotherapeutic Drugs Key Players in India
- 10.3 India Immunotherapeutic Drugs Market Size by Type
- 10.4 India Immunotherapeutic Drugs Market Size by Application
11 Central & South America
- 11.1 Central & South America Immunotherapeutic Drugs Market Size (2014-2019)
- 11.2 Immunotherapeutic Drugs Key Players in Central & South America
- 11.3 Central & South America Immunotherapeutic Drugs Market Size by Type
- 11.4 Central & South America Immunotherapeutic Drugs Market Size by Application
12 International Players Profiles
- 12.1 Roche
- 12.1.1 Roche Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Immunotherapeutic Drugs Introduction
- 12.1.4 Roche Revenue in Immunotherapeutic Drugs Business (2014-2019))
- 12.1.5 Roche Recent Development
- 12.2 Merck
- 12.2.1 Merck Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Immunotherapeutic Drugs Introduction
- 12.2.4 Merck Revenue in Immunotherapeutic Drugs Business (2014-2019)
- 12.2.5 Merck Recent Development
- 12.3 Novartis
- 12.3.1 Novartis Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Immunotherapeutic Drugs Introduction
- 12.3.4 Novartis Revenue in Immunotherapeutic Drugs Business (2014-2019)
- 12.3.5 Novartis Recent Development
- 12.4 Johnson & Johnson
- 12.4.1 Johnson & Johnson Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Immunotherapeutic Drugs Introduction
- 12.4.4 Johnson & Johnson Revenue in Immunotherapeutic Drugs Business (2014-2019)
- 12.4.5 Johnson & Johnson Recent Development
- 12.5 GlaxoSmithKline
- 12.5.1 GlaxoSmithKline Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Immunotherapeutic Drugs Introduction
- 12.5.4 GlaxoSmithKline Revenue in Immunotherapeutic Drugs Business (2014-2019)
- 12.5.5 GlaxoSmithKline Recent Development
- 12.6 AbbVie
- 12.6.1 AbbVie Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Immunotherapeutic Drugs Introduction
- 12.6.4 AbbVie Revenue in Immunotherapeutic Drugs Business (2014-2019)
- 12.6.5 AbbVie Recent Development
- 12.7 ELI Lilly
- 12.7.1 ELI Lilly Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Immunotherapeutic Drugs Introduction
- 12.7.4 ELI Lilly Revenue in Immunotherapeutic Drugs Business (2014-2019)
- 12.7.5 ELI Lilly Recent Development
- 12.8 Amgen
- 12.8.1 Amgen Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Immunotherapeutic Drugs Introduction
- 12.8.4 Amgen Revenue in Immunotherapeutic Drugs Business (2014-2019)
- 12.8.5 Amgen Recent Development
- 12.9 AstraZeneca
- 12.9.1 AstraZeneca Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Immunotherapeutic Drugs Introduction
- 12.9.4 AstraZeneca Revenue in Immunotherapeutic Drugs Business (2014-2019)
- 12.9.5 AstraZeneca Recent Development
- 12.10 Bristol-Mysers Squibb
- 12.10.1 Bristol-Mysers Squibb Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Immunotherapeutic Drugs Introduction
- 12.10.4 Bristol-Mysers Squibb Revenue in Immunotherapeutic Drugs Business (2014-2019)
- 12.10.5 Bristol-Mysers Squibb Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Immunotherapeutic Drugs. Industry analysis & Market Report on Immunotherapeutic Drugs is a syndicated market report, published as Global Immunotherapeutic Drugs Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Immunotherapeutic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
